Sensus Healthcare, Inc. Appoints Ziv Karni as Chief Scientific Officer
February 28, 2019 at 08:00 am EST
Share
Sensus Healthcare, Inc. announced that the Company has appointed Dr. Ziv Karni to the role of Chief Scientific Officer, effective immediately. Dr. Karni, a pioneer in medical technology research and development, has more than 30 years of experience in the development and sales of medical and aesthetic technologies. He will report to Joe Sardano, Sensus Healthcare CEO. Dr. Karni joins Sensus from Alma Lasers, where he has served as Founder, CEO, President and Head of Research and Development for nearly two decades. Prior to forming Alma Lasers, he co-founded two other laser-based companies, OrZiv and LBT. Most recently, Dr. Karni established and serves as President of Zmed Laser, focusing on laser-based solutions for the minimally invasive surgical market.
Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
SENSUS HEALTHCARE, INC. 
